TP53BP2 and steatosis: In conclusion, our study found that MCD diet-induced ASPP2-deficient mice developed moderate steatosis at 10 days and severe steatosis at 40 days, accompanied by significantly lower levels of hepatic EPA and DHA, and the gut microbiota profile in the early-stage of NAFLD.